Murray A Goldberg - Net Worth and Insider Trading
Murray A Goldberg Net Worth
The estimated net worth of Murray A Goldberg is at least $62 Million dollars as of 2024-05-01. Murray A Goldberg is the SVP Administration & Asst Secr of Regeneron Pharmaceuticals Inc and owns about 69,502 shares of Regeneron Pharmaceuticals Inc (REGN) stock worth over $62 Million. Details can be seen in Murray A Goldberg's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Murray A Goldberg has not made any transactions after 2014-10-24 and currently still holds the listed stock(s).
Transaction Summary of Murray A Goldberg
Murray A Goldberg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Murray A Goldberg owns 5 companies in total, including Aerie Pharmaceuticals Inc (AERI) , Ayala Pharmaceuticals Inc (ADXS) , and Teva Pharmaceutical Industries Ltd (TEVA) among others .
Click here to see the complete history of Murray A Goldberg’s form 4 insider trades.
Insider Ownership Summary of Murray A Goldberg
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AERI | Aerie Pharmaceuticals Inc | 2013-10-25 | director |
| ADXS | Ayala Pharmaceuticals Inc | 2020-05-07 | director |
| TEVA | Teva Pharmaceutical Industries Ltd | 2018-01-01 | director |
| REGN | Regeneron Pharmaceuticals Inc | 2014-10-24 | SVP Fin & Admin & CFO & & Treas |
| ADXS | Advaxis Inc | 2023-01-19 | director |
Murray A Goldberg Latest Holdings Summary
Murray A Goldberg currently owns a total of 1 stock. Murray A Goldberg owns 69,502 shares of Regeneron Pharmaceuticals Inc (REGN) as of October 24, 2014, with a value of $62 Million.
Latest Holdings of Murray A Goldberg
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc | 2014-10-24 | 69,502 | 890.59 | 61,897,786 |
Holding Weightings of Murray A Goldberg
Murray A Goldberg Form 4 Trading Tracker
According to the SEC Form 4 filings, Murray A Goldberg has made a total of 0 transactions in Regeneron Pharmaceuticals Inc (REGN) over the past 5 years. The most-recent trade in Regeneron Pharmaceuticals Inc is the sale of 26,788 shares on October 24, 2014, which brought Murray A Goldberg around $11 Million.
Insider Trading History of Murray A Goldberg
- 1
Murray A Goldberg Trading Performance
Murray A Goldberg Ownership Network
Ownership Network List of Murray A Goldberg
Ownership Network Relation of Murray A Goldberg
Murray A Goldberg Owned Company Details
What does Aerie Pharmaceuticals Inc do?
Who are the key executives at Aerie Pharmaceuticals Inc?
Murray A Goldberg is the director of Aerie Pharmaceuticals Inc. Other key executives at Aerie Pharmaceuticals Inc include Chief Financial Officer Peter Frederick Lang , director & Chief Executive Officer Raj Kannan , and Vice President of Finance Jeffrey Calabrese .
Aerie Pharmaceuticals Inc (AERI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aerie Pharmaceuticals Inc (AERI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerie Pharmaceuticals Inc (AERI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aerie Pharmaceuticals Inc (AERI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aerie Pharmaceuticals Inc Insider Transactions
Murray A Goldberg Mailing Address
Above is the net worth, insider trading, and ownership report for Murray A Goldberg. You might contact Murray A Goldberg via mailing address: 2030 Main Street, Suite 1500, Irvine Ca 92614.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
